S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.
Identifieur interne : 002D76 ( PubMed/Corpus ); précédent : 002D75; suivant : 002D77S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.
Auteurs : Heike Hofmann ; Kim Hattermann ; Andrea Marzi ; Thomas Gramberg ; Martina Geier ; Mandy Krumbiegel ; Seraphin Kuate ; Klaus Uberla ; Matthias Niedrig ; Stefan PöhlmannSource :
- Journal of virology [ 0022-538X ] ; 2004.
English descriptors
- KwdEn :
- Animals, Antibodies, Viral (blood), Antibodies, Viral (immunology), Carcinoma, Hepatocellular, Cell Line, Cell Line, Tumor, Humans, Kidney (cytology), Kidney (virology), Lentivirus (genetics), Liver (cytology), Liver (virology), Liver Neoplasms, Membrane Glycoproteins (genetics), Membrane Glycoproteins (immunology), Membrane Glycoproteins (metabolism), Neutralization Tests, Rabbits, SARS Virus (pathogenicity), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (virology), Spike Glycoprotein, Coronavirus, Transfection, Viral Envelope Proteins (genetics), Viral Envelope Proteins (immunology), Viral Envelope Proteins (metabolism), Virion.
- MESH :
- chemical , blood : Antibodies, Viral.
- chemical , genetics : Membrane Glycoproteins, Viral Envelope Proteins.
- chemical , immunology : Antibodies, Viral, Membrane Glycoproteins, Viral Envelope Proteins.
- cytology : Kidney, Liver.
- genetics : Lentivirus.
- immunology : Severe Acute Respiratory Syndrome.
- chemical , metabolism : Membrane Glycoproteins, Viral Envelope Proteins.
- pathogenicity : SARS Virus.
- virology : Kidney, Liver, Severe Acute Respiratory Syndrome.
- Animals, Carcinoma, Hepatocellular, Cell Line, Cell Line, Tumor, Humans, Liver Neoplasms, Neutralization Tests, Rabbits, Spike Glycoprotein, Coronavirus, Transfection, Virion.
Abstract
The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) causes severe pneumonia with a fatal outcome in approximately 10% of patients. SARS-CoV is not closely related to other coronaviruses but shares a similar genome organization. Entry of coronaviruses into target cells is mediated by the viral S protein. We functionally analyzed SARS-CoV S using pseudotyped lentiviral particles (pseudotypes). The SARS-CoV S protein was found to be expressed at the cell surface upon transient transfection. Coexpression of SARS-CoV S with human immunodeficiency virus-based reporter constructs yielded viruses that were infectious for a range of cell lines. Most notably, viral pseudotypes harboring SARS-CoV S infected hepatoma cell lines but not T- and B-cell lines. Infection of the hepatoma cell line Huh-7 was also observed with replication-competent SARS-CoV, indicating that hepatocytes might be targeted by SARS-CoV in vivo. Inhibition of vacuolar acidification impaired infection by SARS-CoV S-bearing pseudotypes, indicating that S-mediated entry requires low pH. Finally, infection by SARS-CoV S pseudotypes but not by vesicular stomatitis virus G pseudotypes was efficiently inhibited by a rabbit serum raised against SARS-CoV particles and by sera from SARS patients, demonstrating that SARS-CoV S is a target for neutralizing antibodies and that such antibodies are generated in SARS-CoV-infected patients. Our results show that viral pseudotyping can be employed for the analysis of SARS-CoV S function. Moreover, we provide evidence that SARS-CoV infection might not be limited to lung tissue and can be inhibited by the humoral immune response in infected patients.
DOI: 10.1128/JVI.78.12.6134-6142.2004
PubMed: 15163706
Links to Exploration step
pubmed:15163706Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.</title><author><name sortKey="Hofmann, Heike" sort="Hofmann, Heike" uniqKey="Hofmann H" first="Heike" last="Hofmann">Heike Hofmann</name><affiliation><nlm:affiliation>Institute for Clinical and Molecular Virology, University Erlangen-Nürnberg, Nikolaus-Fiebiger-Center, Glückstrasse 6, D-91054 Erlangen, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Hattermann, Kim" sort="Hattermann, Kim" uniqKey="Hattermann K" first="Kim" last="Hattermann">Kim Hattermann</name></author><author><name sortKey="Marzi, Andrea" sort="Marzi, Andrea" uniqKey="Marzi A" first="Andrea" last="Marzi">Andrea Marzi</name></author><author><name sortKey="Gramberg, Thomas" sort="Gramberg, Thomas" uniqKey="Gramberg T" first="Thomas" last="Gramberg">Thomas Gramberg</name></author><author><name sortKey="Geier, Martina" sort="Geier, Martina" uniqKey="Geier M" first="Martina" last="Geier">Martina Geier</name></author><author><name sortKey="Krumbiegel, Mandy" sort="Krumbiegel, Mandy" uniqKey="Krumbiegel M" first="Mandy" last="Krumbiegel">Mandy Krumbiegel</name></author><author><name sortKey="Kuate, Seraphin" sort="Kuate, Seraphin" uniqKey="Kuate S" first="Seraphin" last="Kuate">Seraphin Kuate</name></author><author><name sortKey="Uberla, Klaus" sort="Uberla, Klaus" uniqKey="Uberla K" first="Klaus" last="Uberla">Klaus Uberla</name></author><author><name sortKey="Niedrig, Matthias" sort="Niedrig, Matthias" uniqKey="Niedrig M" first="Matthias" last="Niedrig">Matthias Niedrig</name></author><author><name sortKey="Pohlmann, Stefan" sort="Pohlmann, Stefan" uniqKey="Pohlmann S" first="Stefan" last="Pöhlmann">Stefan Pöhlmann</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15163706</idno><idno type="pmid">15163706</idno><idno type="doi">10.1128/JVI.78.12.6134-6142.2004</idno><idno type="wicri:Area/PubMed/Corpus">002D76</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D76</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.</title><author><name sortKey="Hofmann, Heike" sort="Hofmann, Heike" uniqKey="Hofmann H" first="Heike" last="Hofmann">Heike Hofmann</name><affiliation><nlm:affiliation>Institute for Clinical and Molecular Virology, University Erlangen-Nürnberg, Nikolaus-Fiebiger-Center, Glückstrasse 6, D-91054 Erlangen, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Hattermann, Kim" sort="Hattermann, Kim" uniqKey="Hattermann K" first="Kim" last="Hattermann">Kim Hattermann</name></author><author><name sortKey="Marzi, Andrea" sort="Marzi, Andrea" uniqKey="Marzi A" first="Andrea" last="Marzi">Andrea Marzi</name></author><author><name sortKey="Gramberg, Thomas" sort="Gramberg, Thomas" uniqKey="Gramberg T" first="Thomas" last="Gramberg">Thomas Gramberg</name></author><author><name sortKey="Geier, Martina" sort="Geier, Martina" uniqKey="Geier M" first="Martina" last="Geier">Martina Geier</name></author><author><name sortKey="Krumbiegel, Mandy" sort="Krumbiegel, Mandy" uniqKey="Krumbiegel M" first="Mandy" last="Krumbiegel">Mandy Krumbiegel</name></author><author><name sortKey="Kuate, Seraphin" sort="Kuate, Seraphin" uniqKey="Kuate S" first="Seraphin" last="Kuate">Seraphin Kuate</name></author><author><name sortKey="Uberla, Klaus" sort="Uberla, Klaus" uniqKey="Uberla K" first="Klaus" last="Uberla">Klaus Uberla</name></author><author><name sortKey="Niedrig, Matthias" sort="Niedrig, Matthias" uniqKey="Niedrig M" first="Matthias" last="Niedrig">Matthias Niedrig</name></author><author><name sortKey="Pohlmann, Stefan" sort="Pohlmann, Stefan" uniqKey="Pohlmann S" first="Stefan" last="Pöhlmann">Stefan Pöhlmann</name></author></analytic><series><title level="j">Journal of virology</title><idno type="ISSN">0022-538X</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antibodies, Viral (blood)</term><term>Antibodies, Viral (immunology)</term><term>Carcinoma, Hepatocellular</term><term>Cell Line</term><term>Cell Line, Tumor</term><term>Humans</term><term>Kidney (cytology)</term><term>Kidney (virology)</term><term>Lentivirus (genetics)</term><term>Liver (cytology)</term><term>Liver (virology)</term><term>Liver Neoplasms</term><term>Membrane Glycoproteins (genetics)</term><term>Membrane Glycoproteins (immunology)</term><term>Membrane Glycoproteins (metabolism)</term><term>Neutralization Tests</term><term>Rabbits</term><term>SARS Virus (pathogenicity)</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Spike Glycoprotein, Coronavirus</term><term>Transfection</term><term>Viral Envelope Proteins (genetics)</term><term>Viral Envelope Proteins (immunology)</term><term>Viral Envelope Proteins (metabolism)</term><term>Virion</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Membrane Glycoproteins</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term><term>Membrane Glycoproteins</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Kidney</term><term>Liver</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Lentivirus</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Membrane Glycoproteins</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Kidney</term><term>Liver</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Carcinoma, Hepatocellular</term><term>Cell Line</term><term>Cell Line, Tumor</term><term>Humans</term><term>Liver Neoplasms</term><term>Neutralization Tests</term><term>Rabbits</term><term>Spike Glycoprotein, Coronavirus</term><term>Transfection</term><term>Virion</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) causes severe pneumonia with a fatal outcome in approximately 10% of patients. SARS-CoV is not closely related to other coronaviruses but shares a similar genome organization. Entry of coronaviruses into target cells is mediated by the viral S protein. We functionally analyzed SARS-CoV S using pseudotyped lentiviral particles (pseudotypes). The SARS-CoV S protein was found to be expressed at the cell surface upon transient transfection. Coexpression of SARS-CoV S with human immunodeficiency virus-based reporter constructs yielded viruses that were infectious for a range of cell lines. Most notably, viral pseudotypes harboring SARS-CoV S infected hepatoma cell lines but not T- and B-cell lines. Infection of the hepatoma cell line Huh-7 was also observed with replication-competent SARS-CoV, indicating that hepatocytes might be targeted by SARS-CoV in vivo. Inhibition of vacuolar acidification impaired infection by SARS-CoV S-bearing pseudotypes, indicating that S-mediated entry requires low pH. Finally, infection by SARS-CoV S pseudotypes but not by vesicular stomatitis virus G pseudotypes was efficiently inhibited by a rabbit serum raised against SARS-CoV particles and by sera from SARS patients, demonstrating that SARS-CoV S is a target for neutralizing antibodies and that such antibodies are generated in SARS-CoV-infected patients. Our results show that viral pseudotyping can be employed for the analysis of SARS-CoV S function. Moreover, we provide evidence that SARS-CoV infection might not be limited to lung tissue and can be inhibited by the humoral immune response in infected patients.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15163706</PMID><DateCompleted><Year>2004</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>78</Volume><Issue>12</Issue><PubDate><Year>2004</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J. Virol.</ISOAbbreviation></Journal><ArticleTitle>S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.</ArticleTitle><Pagination><MedlinePgn>6134-42</MedlinePgn></Pagination><Abstract><AbstractText>The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) causes severe pneumonia with a fatal outcome in approximately 10% of patients. SARS-CoV is not closely related to other coronaviruses but shares a similar genome organization. Entry of coronaviruses into target cells is mediated by the viral S protein. We functionally analyzed SARS-CoV S using pseudotyped lentiviral particles (pseudotypes). The SARS-CoV S protein was found to be expressed at the cell surface upon transient transfection. Coexpression of SARS-CoV S with human immunodeficiency virus-based reporter constructs yielded viruses that were infectious for a range of cell lines. Most notably, viral pseudotypes harboring SARS-CoV S infected hepatoma cell lines but not T- and B-cell lines. Infection of the hepatoma cell line Huh-7 was also observed with replication-competent SARS-CoV, indicating that hepatocytes might be targeted by SARS-CoV in vivo. Inhibition of vacuolar acidification impaired infection by SARS-CoV S-bearing pseudotypes, indicating that S-mediated entry requires low pH. Finally, infection by SARS-CoV S pseudotypes but not by vesicular stomatitis virus G pseudotypes was efficiently inhibited by a rabbit serum raised against SARS-CoV particles and by sera from SARS patients, demonstrating that SARS-CoV S is a target for neutralizing antibodies and that such antibodies are generated in SARS-CoV-infected patients. Our results show that viral pseudotyping can be employed for the analysis of SARS-CoV S function. Moreover, we provide evidence that SARS-CoV infection might not be limited to lung tissue and can be inhibited by the humoral immune response in infected patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hofmann</LastName><ForeName>Heike</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Clinical and Molecular Virology, University Erlangen-Nürnberg, Nikolaus-Fiebiger-Center, Glückstrasse 6, D-91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hattermann</LastName><ForeName>Kim</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Marzi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gramberg</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Geier</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Krumbiegel</LastName><ForeName>Mandy</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kuate</LastName><ForeName>Seraphin</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Uberla</LastName><ForeName>Klaus</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Niedrig</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pöhlmann</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016086" MajorTopicYN="N">Lentivirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011817" MajorTopicYN="N">Rabbits</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>5</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>6</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>5</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15163706</ArticleId><ArticleId IdType="doi">10.1128/JVI.78.12.6134-6142.2004</ArticleId><ArticleId IdType="pii">78/12/6134</ArticleId><ArticleId IdType="pmc">PMC416513</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wkly Epidemiol Rec. 2003 Apr 4;78(14):97-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12723281</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):2030-1</Citation><ArticleIdList><ArticleId IdType="pubmed">12672880</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 May 15;423(6937):240</Citation><ArticleIdList><ArticleId IdType="pubmed">12748632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1994 Oct;75 ( Pt 10):2595-606</Citation><ArticleIdList><ArticleId IdType="pubmed">7931146</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Feb;69(2):684-94</Citation><ArticleIdList><ArticleId IdType="pubmed">7815531</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Jun 21;326(7403):1358-62</Citation><ArticleIdList><ArticleId IdType="pubmed">12816821</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2003 Jul;200(3):282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12845623</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Yi Jun Yi Da Xue Xue Bao. 2003 Jul;23(7):637-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12865207</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Jul 18;301(5631):297-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12869736</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2003 Aug;77(16):8801-11</Citation><ArticleIdList><ArticleId IdType="pubmed">12885899</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin Med J (Engl). 2003 Jul;116(7):976-80</Citation><ArticleIdList><ArticleId IdType="pubmed">12890365</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Gan Zang Bing Za Zhi. 2003 Jul;11(7):418-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12890346</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1989 Jan;168(1):162-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2535900</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1989 Aug;171(2):493-502</Citation><ArticleIdList><ArticleId IdType="pubmed">2548329</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1990 Feb 25;18(4):937-47</Citation><ArticleIdList><ArticleId IdType="pubmed">1690394</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1995 Feb 1;206(2):935-44</Citation><ArticleIdList><ArticleId IdType="pubmed">7531918</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Nov;69(11):6705-11</Citation><ArticleIdList><ArticleId IdType="pubmed">7474080</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 1995 Oct;131(2):339-49</Citation><ArticleIdList><ArticleId IdType="pubmed">7593163</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1995 Dec 20;214(2):453-63</Citation><ArticleIdList><ArticleId IdType="pubmed">8553547</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1996 Apr 15;15(8):2020-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8617249</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Biol. 1997 Jan;200(Pt 1):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9023991</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1997 Dec;71(12):9278-84</Citation><ArticleIdList><ArticleId IdType="pubmed">9371586</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1998 May 10;244(2):483-94</Citation><ArticleIdList><ArticleId IdType="pubmed">9601516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 2003 Aug 4;162(3):371-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12900390</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2003 Aug 29;331(5):991-1004</Citation><ArticleIdList><ArticleId IdType="pubmed">12927536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Gan Zang Bing Za Zhi. 2003 Aug;11(8):493-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12939186</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2003 Sep 15;37(6):857-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12955652</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2003 Oct;77(19):10179-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12970403</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Oct 10;302(5643):276-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12958366</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Yi Jun Yi Da Xue Xue Bao. 2003 Nov;23(11):1125-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14625166</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 2003 Dec;49(12):1989-96</Citation><ArticleIdList><ArticleId IdType="pubmed">14633869</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64</Citation><ArticleIdList><ArticleId IdType="pubmed">14651994</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Dec 6;362(9399):1895-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14667748</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2004 Jan 23;313(4):938-47</Citation><ArticleIdList><ArticleId IdType="pubmed">14706633</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 1980 Feb;84(2):404-20</Citation><ArticleIdList><ArticleId IdType="pubmed">6991511</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1982 Jun;119(2):358-71</Citation><ArticleIdList><ArticleId IdType="pubmed">6281979</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1984 Jan 30;132(2):261-70</Citation><ArticleIdList><ArticleId IdType="pubmed">6199889</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antibiot (Tokyo). 1984 Feb;37(2):110-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6423597</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cell Biol. 1984 Mar;33(2):281-93</Citation><ArticleIdList><ArticleId IdType="pubmed">6325194</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1986 Jul;59(1):168-71</Citation><ArticleIdList><ArticleId IdType="pubmed">3012115</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1988 Feb;7(2):513-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3259178</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1988 Nov;85(21):7972-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2973058</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation><ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12781536</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 1990 Apr;10(4):1805-10</Citation><ArticleIdList><ArticleId IdType="pubmed">1690852</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1990 Apr;71 ( Pt 4):767-73</Citation><ArticleIdList><ArticleId IdType="pubmed">2157795</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1990 Sep;64(9):4589-92</Citation><ArticleIdList><ArticleId IdType="pubmed">2166833</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1991 Jul 25;19(14):3979-86</Citation><ArticleIdList><ArticleId IdType="pubmed">1650459</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 1991 Dec 15;108(2):193-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1660837</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry. 1993 Apr 20;32(15):3902-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8385991</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1993 Dec;67(12):7394-401</Citation><ArticleIdList><ArticleId IdType="pubmed">8230460</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Oct;68(10):6523-34</Citation><ArticleIdList><ArticleId IdType="pubmed">8083990</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1999 Oct 25;263(2):265-72</Citation><ArticleIdList><ArticleId IdType="pubmed">10544100</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Feb;74(3):1393-406</Citation><ArticleIdList><ArticleId IdType="pubmed">10627550</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Nov;74(21):10074-80</Citation><ArticleIdList><ArticleId IdType="pubmed">11024136</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2000 Oct 25;276(2):229-37</Citation><ArticleIdList><ArticleId IdType="pubmed">11040114</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2001 Jan 20;279(2):371-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11162792</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1995 Apr 1;208(1):67-74</Citation><ArticleIdList><ArticleId IdType="pubmed">11831732</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2002 Jul;83(Pt 7):1535-45</Citation><ArticleIdList><ArticleId IdType="pubmed">12075072</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2002 Sep;76(17):8518-31</Citation><ArticleIdList><ArticleId IdType="pubmed">12163571</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2002 Sep 15;301(1):109-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12359451</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2002 Dec 4;532(1-2):107-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12459472</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2003 Jan 5;305(1):115-23</Citation><ArticleIdList><ArticleId IdType="pubmed">12504546</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2003 Apr;77(8):4597-608</Citation><ArticleIdList><ArticleId IdType="pubmed">12663766</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2003 May;77(9):5324-32</Citation><ArticleIdList><ArticleId IdType="pubmed">12692234</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D76 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002D76 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:15163706
|texte= S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15163706" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |